United States

Globus Medical Inc (GMED.N)

GMED.N on New York Stock Exchange

20 Oct 2017
Change (% chg)

$0.48 (+1.59%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative... (more)


Beta: 0.55
Market Cap(Mil.): $2,951.35
Shares Outstanding(Mil.): 96.29
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 33.06 16.52
EPS (TTM): -- -- --
ROI: -- 13.87 11.32
ROE: -- 16.68 15.18

BRIEF-Globus Medical ‍expects first revenues from sale of ExcelsiusGPS systems in Q4 2017

* Globus Medical announces first spine surgeries using ExcelsiusGPS

Oct 10 2017

BRIEF-Globus Medical appoints David Demski as CEO

* Globus Medical Inc - ‍Paul will remain in role of executive chairman​

Aug 29 2017

BRIEF-Globus Medical announces FDA 510(k) clearance for Excelsius GPS

* Globus Medical announces FDA 510(k) clearance for Excelsius GPS™ Source text for Eikon: Further company coverage:

Aug 17 2017

BRIEF-Globus Medical says received letter from FDA regarding 510(K) submission for Excelsiusgps

* Globus Medical - received letter from FDA informing co had not sufficiently addressed questions regarding 510(K) submission for Excelsiusgps

May 17 2017

BRIEF-Globus Medical reports Q1 earnings per share of $0.30

* Q1 earnings per share view $0.31 -- Thomson Reuters I/B/E/S

May 03 2017

Earnings vs. Estimates